We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn about our cookie policy.
Miltenyi Biotec Detection Of Arginase-1+ Cells; 200 mL
List Price $566.50 Your Price $566.50
Miltenyi Biotec Detection of Arginase-1+ Cells - MLTY (Additional S&H or Hazmat Fees May Apply)
NETA PART: MLTY-130-127-835
MFG.PART: 130-127-835
UNSPSC: 12352203
Manufacturer: Miltenyi Biotec


Miltenyi Biotec Clone REAL1137 is an antibody fragment derived from the full Arginase-1 antibody molecule. It displays no binding to Fc receptors. The recombinantly engineered antibody fragments are multimerized to form the REAdye_lease Complex to bind markers with high avidity. | Clone REAL1137 recognizes the isoenzyme Arginase-1, also known as ARG1, which is a member of the ureohydrolase family of enzymes. Arginase-1 converts L-arginine into L-ornithine and urea, which is then converted to polyamine. This process takes place primarily in the liver and, to a lesser extent, in the kidneys. Arginase -1 is also expressed in granulocytes, neural stem cells, and in myeloid derived suppressor cells (MDSC) and plays a role in the antimicrobial effector pathway in polymorphonuclear granulocytes. Mutations, which cause Arginase deficiency, can lead to defects in the urea cycle with hyperammonaemia. Arginase-1 is reported to be expressed in colorectal cancer and is found in the majority of hepatocellular carcinomas. | For removal of REAdye_lease fluorochromes for optional relabeling with different fluorochrome-conjugated REAdye_lease antibodies use the REAlease Support Kit (130-120-675). - MLTY (Additional S&H or Hazmat Fees May Apply)
| SKU | MLTY-130-127-835 |
|---|---|
| Supplier Part Number | 130-127-835 |
| UM | EA |
| UNSPSC | 12352203 |
| Manufacturer | Miltenyi Biotec |
| MSDS URL | Click here |
| ProductLine | MLTY |
| Qty | 1 |
| MinOrderQty | 1 |
| Weight | 7.000000 |
| Lead Time | 5 |
| Hazardous | N |
| Energy Star | No |
| Green | No |
| Controlled | N |

